GSK: The AI-Driven Science Factory
AI Rebuilds $50B Pharma Giant's Thinking, Plan Could Help Every Data-Driven Firm
GSK is redesigning pharmaceutical research around AI, from data infrastructure to autonomous scientific agents. Its platforms accelerate hypothesis generation, imaging analysis and drug discovery workflows, offering CIOs a blueprint for enterprise-scale AI transformation in regulated industries.
GSK is redesigning pharmaceutical research around AI, from data infrastructure to autonomous scientific agents. Its platforms accelerate hypothesis generation, imaging analysis and drug discovery workflows, offering CIOs a blueprint for enterprise-scale AI transformation in regulated industries.